Physician profile
James R Hoffman
NPI 1730115759
$795,104.63
in general payments reported to CMS, 2019-2025
19 companies · $122K in 2025
The $122K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $29K · 2021: $144K · 2022: $123K · 2023: $154K · 2024: $139K · 2025: $122K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $308K · Travel and Lodging: $71K · Consulting Fee: $20K · Food and Beverage: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $307,762.50 |
| Travel and Lodging | $70,906.57 |
| Consulting Fee | $20,200.00 |
| Food and Beverage | $15,310.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $875.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $504,921.15 | 2022-2025 | Infuse, Infuse Multifocal, Revive |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $222,364.40 | 2019-2021 | |
| Allergan, INC. | $52,821.99 | 2019-2022 | |
| Abbvie INC. | $12,550.98 | 2022-2023 | |
| Alcon Vision LLC | $530.51 | 2019-2024 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $474.62 | 2025 | Acuvue |
| Coopervision INC. | $319.54 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Optos, INC. | $228.66 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $134.36 | 2021 | |
| Horizon Therapeutics Plc | $117.39 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $114.75 | 2024 | Xdemvy |
| Argenx US, INC. | $110.93 | 2025 | |
| Shire North American Group INC | $109.72 | 2019 | |
| Abb Con-Cise Optical Group LLC | $91.74 | 2019-2025 | Spectacle Lenses, Contact Lens |
| Sun Pharmaceutical Industries INC. | $90.99 | 2021-2023 | Cequa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $53.73 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.65 | 2019-2020 | |
| Alcon Research LLC | $17.89 | 2019 | |
| Amgen INC. | $16.63 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.